Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DX
2726
Dynex Capital
DX
$3.23B
| $698K | ﹤0.01% |
48,800
+37,300
| +324% | +$499K |
|
|
SCHV
2727
Schwab US Large-Cap Value ETF
SCHV
$16.3B
| $697K | ﹤0.01% |
+41,700
| New | +$681K |
|
2728
Walker & Dunlop
WD
$1.47B
| $696K | ﹤0.01% |
13,700
-27,000
| -66% | -$1.1M |
|
|
DVD
2729
DELISTED
Dover Motorsports
DVD
| $696K | ﹤0.01% |
448,717
+20,637
| +5% | +$27.8K |
|
|
FSTX
2730
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $695K | ﹤0.01% |
118,133
+33,901
| +40% | +$196K |
|
|
IGMS
2731
DELISTED
IGM Biosciences
IGMS
| $694K | ﹤0.01% |
+9,500
| New | +$577K |
|
2732
Mannatech
MTEX
$9.78M
| $692K | ﹤0.01% |
46,788
+5,771
| +14% | +$75.6K |
|
2733
Murphy Oil
MUR
$4.99B
| $692K | ﹤0.01% |
50,114
-286,086
| -85% | -$3.29M |
|
2734
State Street SPDR S&P Regional Banking ETF
KRE
$4.67B
| $691K | ﹤0.01% |
18,000
-7,300
| -29% | -$267K |
|
|
FRG
2735
DELISTED
Franchise Group, Inc.
FRG
| $691K | ﹤0.01% |
+31,600
| New | +$504K |
|
2736
KB Financial Group
KB
$41.4B
| $690K | ﹤0.01% |
24,800
-19,300
| -44% | -$527K |
|
2737
OP Bancorp
OPBK
$235M
| $687K | ﹤0.01% |
99,500
+30,800
| +45% | +$207K |
|
|
CXDC
2738
DELISTED
China XD Plastics Company Limited
CXDC
| $687K | ﹤0.01% |
597,580
-8,400
| -1% | -$8.16K |
|
2739
Invesco S&P 500 Pure Growth ETF
RPG
$2.09B
| $686K | ﹤0.01% |
+26,500
| New | +$632K |
|
2740
Cabaletta Bio
CABA
$442M
| $685K | ﹤0.01% |
61,447
+48,447
| +373% | +$371K |
|
2741
Vanguard Morningstar Small-Cap ETF
VB
$83.4B
| $685K | ﹤0.01% |
4,700
+1,800
| +62% | +$242K |
|
2742
AMREP Corp
AXR
$118M
| $683K | ﹤0.01% |
151,400
+8,300
| +6% | +$36.3K |
|
2743
ClearOne Inc
CLRO
$15.2M
| $682K | ﹤0.01% |
22,730
+4,865
| +27% | +$136K |
|
|
CGRN
2744
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| $680K | ﹤0.01% |
225,130
+8,203
| +4% | +$17.3K |
|
2745
Andersons Inc
ANDE
$2.21B
| $679K | ﹤0.01% |
+49,376
| New | +$717K |
|
2746
SK Telecom
SKM
$14.1B
| $678K | ﹤0.01% |
+21,306
| New | +$658K |
|
2747
SuperCom
SPCB
$70.3M
| $678K | ﹤0.01% |
2,118
+1,531
| +261% | +$398K |
|
2748
Investar Holding Corp
ISTR
$424M
| $677K | ﹤0.01% |
46,675
-51,700
| -53% | -$659K |
|
|
BLU
2749
DELISTED
BELLUS Health Inc.
BLU
| $677K | ﹤0.01% |
65,438
+5,339
| +9% | +$54.1K |
|
2750
InflaRx
IFRX
$296M
| $676K | ﹤0.01% |
+147,373
| New | +$956K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.